• BX Home
  • Business of Biotechnology: Blog [Page 5]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

BUSINESS OF BIOTECHNOLOGY

They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.

Business of Biotechnology is part of Business Exchange, suggested by Arlene Weintraub. This topic contains 1,248 news and 4,696 blog items. Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from like-minded professionals.

Blogs

Recent blog posts on this topic.

AstraZeneca, Aussie biotech outfit ally in $240M-plus discovery dealmore

AstraZeneca's partnership spree of the last two months has gone Down Under. As the company shrinks its internal...

Scientific American Worldview Issue 5 at #BIO2013more

Copyright © thinkBiotech I continue to measure global biotechnology innovation in the fifth  edition of Scientific...

BIO: R&D execs say tweaks boost drug-development processmore

Panel from left to right: Jose-Carlos Gutiérrez-Ramos, Pfizer; Briggs Morrison, AstraZeneca; John Carroll,...

Chicago uses its turn in BIO spotlight to promote incubator plansmore

The city of Chicago is hoping to take advantage of the spotlight of the annual BIO convention to build up its biotech...

Which pharmaceutical companies face the most patent expirations this y...more

Copyright © thinkBiotech This infographic from DrugPatentWatch shows that Sanofi Aventis...

Moody's: Deep-pocketed pharma giants poised to boost M&A activity ...more

Here's a multibillion-dollar question: With their improved cash positions, will pharma companies increase spending this...

Gilead keeps lead in hep C race after rivals post key trial resultsmore

After delivering data from multiple rounds of trials on all-oral combos against hepatitis C, pharma runners appear to...

Book signings at #bio2013more

Copyright © thinkBiotech Join Michael Salgaller and I as we will be signing our books at the BIO bookstore on Tuesday...

E&Y: Biotech budget hawks rule the roost in year of mixed performa...more

Public biotech companies around the world stayed on a healthy pace last year, boosting top and bottom-line revenue...

Drug Patent Expirations for Mar 26 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 16 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

GlaxoSmithKline and Avalon Ventures forge $495M biotech startup allian...more

GlaxoSmithKline ($GSK) has a new plan to improve the economics of investing in drug discovery. The London-based drug...

The Answers are in the Crowd? (Part 2) [live from #bio2013]more

Copyright © thinkBiotech This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a...

Updated: EU pharma CEOs earned 46% less than U.S. peersmore

CEO pay in Europe continues to be a flashpoint given the high unemployment and austerity measures the workaday folk on...

Bristol-Myers rebounds on hep C front with new Merck partnershipmore

Like most of its new drug programs in recent years, Merck's ($MRK) work on new hepatitis C drugs has never quite paid...

The Top 15 Biotech VC firmsmore

Ask any biotech exec in the business of drug and device development about the funding environment these days, and...

Which Drug Companies Listed the Most Patents Last Yearmore

Copyright © thinkBiotech This infographic shows the pharmaceutical companies that listed the most patents last year.

AstraZeneca works both sides of the Atlantic in forging new cancer dru...more

While AstraZeneca's busy business development team was fashioning a new discovery deal with Bind Therapeutics in...

Biotechnology and Pharmaceutical Industry Infographics #BIO2013more

Copyright © thinkBiotech These infographics from DrugPatentWatch.com and BiologicPatentWatch.com track innovation and...

AstraZeneca and Boston biotech unite to blast cancer with a nanotech d...more

AstraZeneca has found another partner in an ongoing love fest with biotech startups. The drug giant ($AZN), which is in...

Drug Patent Expirations for Apr 3 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 14 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 16 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 26 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 3 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Top Sources: Business of Biotechnology

  • Biotech Blog
  • News
  • Health Beat
  • frontendofinnovation.blogspot.com
  • Nature Biotechnology
  • The Biotech Weblog
  • policyinnovations.org
  • Science Progress
  • LinkedIn Answers: Technology
  • World Pharma News / Published News

Most Active Users in this Topic

see all contributors in Business of Biotechnology

Featured White Papers

Post a Job

Jobs in this Topic

Process Sciences Associate Drug Product Regeneron | Rensselaer, NY
Posted: May 8
Research Associate - Biotechnology William Blair Company, L.L.C | New York, NY
Posted: Apr 19

Report comment contains invalid characters. ()
cancel
Search Cancel